IP Library Granted Patent US 12679883
Granted Patent B2
US 12679883 · App. 17/627,337 · Granted Jul 14, 2026

Innovative production technique for antibody-enzyme

Inventors: Taizo Uda (Oita, JP); Emi Hifumi (Oita, JP)
Assignee: JAPAN SCIENCE AND TECHNOLOGY AGENCY
C07K16/06C07K1/16C07K16/065C07K2317/21
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12679883
App. No.
17/627,337
Granted
Jul 14, 2026
Kind
B2
Abstract

A method for producing a κ light chain antibody having enzyme activity or improved enzyme activity includes modifying a polynucleotide that encodes a κ light chain antibody having a polypeptide having an amino acid sequence where the 95th amino acid residue from the N-terminal of a variable region by the Kabat classification is a proline residue, to delete or substitute the proline residue and to obtain a polynucleotide that encodes a κ light chain antibody having a polypeptide having an amino acid sequence where the 95th amino acid residue from the N-terminal of a variable region by the Kabat classification is deleted or substituted with an amino acid residue other than a proline residue, and expressing a κ light chain antibody having enzyme activity in an intracellular or extracellular expression system by using an expression vector including the polynucleotide that encodes a κ light chain antibody obtained after modification.

Claims (40)

1 . A method for producing a κ light chain antibody having enzyme activity or improved enzyme activity, the method comprising:

a modification step comprising modifying a polynucleotide that encodes a κ light chain antibody having, as a variable region, a polypeptide having an amino acid sequence in which the 95th amino acid residue from the N-terminal of a variable region by the Kabat classification is a proline residue, by deleting or substituting the proline residue and obtaining a polynucleotide that encodes a κ light chain antibody having, as a variable region, a polypeptide having an amino acid sequence in which the 95th amino acid residue from the N-terminal of a variable region by the Kabat classification is deleted or substituted with an amino acid residue other than a proline residue; and

an expression step comprising expressing a κ light chain antibody having enzyme activity in an intracellular or extracellular expression system by using an expression vector including the polynucleotide that encodes a κ light chain antibody obtained after the modification step.

2 . The production method according to claim 1 ,

wherein the κ light chain antibody is a human κ light chain antibody or a mouse κ light chain antibody.

3 . The production method according to claim 1 ,

wherein a variable region of the κ light chain antibody having enzyme activity or improved enzyme activity is a polypeptide selected from the group consisting of the following (1a) to (3c),

(1a) a polypeptide having an amino acid sequence obtained by deletion or substitution of the 95th proline residue from the N-terminal of a variable region by the Kabat classification in an amino acid sequence represented by SEQ ID NO: 1;

(1b) a polypeptide having an amino acid sequence which is obtained by substitution, addition, or deletion of one or more amino acids in the amino acid sequence of the polypeptide (1a) and in which the 95th amino acid residue from the N-terminal of a variable region by the Kabat classification is deleted or substituted with an amino acid residue other than a proline residue;

(1c) a polypeptide having an amino acid sequence which shares 90% or more identity with the amino acid sequence of the polypeptide (1a) and in which the 95th amino acid residue from the N-terminal of a variable region by the Kabat classification is deleted or substituted with an amino acid residue other than a proline residue;

(2a) an amino acid sequence obtained by deletion or substitution of the 95th proline residue from the N-terminal of a variable region by the Kabat classification in an amino acid sequence represented by SEQ ID NO: 2;

(2b) a polypeptide having an amino acid sequence which is obtained by substitution, addition, or deletion of one or more amino acids in the amino acid sequence of the polypeptide (2a) and in which the 95th amino acid residue from the N-terminal of a variable region by the Kabat classification is deleted or substituted with an amino acid residue other than a proline residue;

(2c) a polypeptide having an amino acid sequence which shares 90% or more identity with the amino acid sequence of the polypeptide (2a) and in which the 95th amino acid residue from the N-terminal of a variable region by the Kabat classification is deleted or substituted with an amino acid residue other than a proline residue;

(3a) an amino acid sequence obtained by deletion or substitution of the 95th proline residue from the N-terminal of a variable region by the Kabat classification in an amino acid sequence represented by SEQ ID NO: 3;

(3b) a polypeptide having an amino acid sequence which is obtained by substitution, addition, or deletion of one or more amino acids in the amino acid sequence of the polypeptide (3a) and in which the 95th amino acid residue from the N-terminal of a variable region by the Kabat classification is deleted or substituted with an amino acid residue other than a proline residue;

(3c) a polypeptide having an amino acid sequence which shares 90% or more identity with the amino acid sequence of the polypeptide (3a) and in which the 95th amino acid residue from the N-terminal of a variable region by the Kabat classification is deleted or substituted with an amino acid residue other than a proline residue.

4 . The production method according to claim 1 ,

wherein a variable region of the κ light chain antibody having enzyme activity or improved enzyme activity is a polypeptide selected from the group consisting of the following (4a) to (7c),

(4a) a polypeptide having an amino acid sequence represented by SEQ ID NO: 4;

(4b) a polypeptide having an amino acid sequence which is obtained by substitution, addition, or deletion of one or more amino acids in the amino acid sequence represented by SEQ ID NO: 4 and in which the 95th amino acid residue from the N-terminal of a variable region by the Kabat classification is deleted or substituted with an amino acid residue other than a proline residue;

(4c) a polypeptide having an amino acid sequence which shares 90% or more identity with the amino acid sequence represented by SEQ ID NO: 4 and in which the 95th amino acid residue from the N-terminal of a variable region by the Kabat classification is deleted or substituted with an amino acid residue other than a proline residue;

(5a) a polypeptide having an amino acid sequence represented by SEQ ID NO: 5;

(5b) a polypeptide having an amino acid sequence which is obtained by substitution, addition, or deletion of one or more amino acids in the amino acid sequence represented by SEQ ID NO: 5 and in which the 95th amino acid residue from the N-terminal of a variable region by the Kabat classification is deleted or substituted with an amino acid residue other than a proline residue;

(5c) a polypeptide having an amino acid sequence which shares 90% or more identity with the amino acid sequence represented by SEQ ID NO: 5 and in which the 95th amino acid residue from the N-terminal of a variable region by the Kabat classification is deleted or substituted with an amino acid residue other than a proline residue;

(6a) a polypeptide having an amino acid sequence represented by SEQ ID NO: 6;

(6b) a polypeptide having an amino acid sequence which is obtained by substitution, addition, or deletion of one or more amino acids in the amino acid sequence represented by SEQ ID NO: 6 and in which the 95th amino acid residue from the N-terminal of a variable region by the Kabat classification is deleted or substituted with an amino acid residue other than a proline residue;

(6c) a polypeptide having an amino acid sequence which shares 90% or more identity with the amino acid sequence represented by SEQ ID NO: 6 and in which the 95th amino acid residue from the N-terminal of a variable region by the Kabat classification is deleted or substituted with an amino acid residue other than a proline residue;

(7a) a polypeptide having an amino acid sequence represented by SEQ ID NO: 7;

(7b) a polypeptide having an amino acid sequence which is obtained by substitution, addition, or deletion of one or more amino acids in the amino acid sequence represented by SEQ ID NO: 7 and in which the 95th amino acid residue from the N-terminal of a variable region by the Kabat classification is deleted or substituted with an amino acid residue other than a proline residue;

(7c) a polypeptide having an amino acid sequence which shares 90% or more identity with the amino acid sequence represented by SEQ ID NO: 7 and in which the 95th amino acid residue from the N-terminal of a variable region by the Kabat classification is deleted or substituted with an amino acid residue other than a proline residue.

5 . The production method according to claim 1 ,

wherein a variable region of the κ light chain antibody having enzyme activity or improved enzyme activity is a polypeptide selected from the group consisting of the following (8a) to (8c),

(8a) an amino acid sequence obtained by deletion or substitution of the 95th proline residue from the N-terminal of a variable region by the Kabat classification in an amino acid sequence represented by SEQ ID NO: 8;

(8b) a polypeptide having an amino acid sequence which is obtained by substitution, addition, or deletion of one or more amino acids in the amino acid sequence of the polypeptide (8a) and in which the 95th amino acid residue from the N-terminal of a variable region by the Kabat classification is deleted or substituted with an amino acid residue other than a proline residue;

(8c) a polypeptide having an amino acid sequence which shares 90% or more identity with the amino acid sequence of the polypeptide (8a) and in which the 95th amino acid residue from the N-terminal of a variable region by the Kabat classification is deleted or substituted with an amino acid residue other than a proline residue.

6 . The production method according to claim 1 ,

wherein a variable region of the κ light chain antibody having enzyme activity is a polypeptide selected from the group consisting of the following (9a) to (9c),

(9a) a polypeptide having an amino acid sequence represented by SEQ ID NO: 9;

(9b) a polypeptide having an amino acid sequence which is obtained by substitution, addition, or deletion of one or more amino acids in the amino acid sequence represented by SEQ ID NO: 9 and in which the 95th amino acid residue from the N-terminal of a variable region by the Kabat classification is deleted or substituted with an amino acid residue other than a proline residue;

(9c) a polypeptide having an amino acid sequence which shares 90% or more identity with the amino acid sequence represented by SEQ ID NO: 9 and in which the 95th amino acid residue from the N-terminal of a variable region by the Kabat classification is deleted or substituted with an amino acid residue other than a proline residue.